deltatrials
Unknown PHASE4 INTERVENTIONAL NCT00120601

Trial for the Treatment of Alcohol Dependence

The Role of Pharmacotherapy in Prevention of Relapse in Alcohol Dependence

Sponsor: National Health and Medical Research Council, Australia

Conditions Alcoholism
Updated 5 times since 2017 Last updated: Jul 15, 2005 Started: Mar 31, 2003 Completion: Jun 30, 2005
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Alcoholism, this trial is ongoing. The trial is conducted by National Health and Medical Research Council, Australia and has accumulated 5 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 23 months · monthly snapshotUnknown

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown StatusUnknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE4

    First recorded

Mar 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Health and Medical Research Council, Australia
  • South Eastern Area Health Service
  • Sydney South West Area Health Service
  • University of Sydney
  • Wentworth Area Health Services
Data source: University of Sydney

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations